Skip to main content
Log in

The Protective Effect of Transit Bipartition and Its Modification Against Sleeve Gastrectomy-Related Esophagitis in a Rodent Model

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The protective effect of transit bipartition against esophagitis has not yet been proven. Thus, we investigate and compare the bariatric outcomes and esophagus’ histological changes of sleeve gastrectomy (SG), SG with transit bipartition (SG-TB), and the proximal SG-TB (SG-PTB) in a rodent model.

Methods

This study included 45 diabetic Sprague–Dawley rats assigned to one of the four groups, SG-PTB (n = 15), SG-TB (n = 12), SG (n = 10), and SHAM (n = 8). Eight surviving rats from each group were included for further investigation. Histological analysis of the gastroesophageal junction was performed. Body weight, food intake, glucose control, and hormonal changes (glucagon-like peptide-1 and insulin) were assessed before and after surgery in all groups.

Results

Preoperatively, no significant differences were observed in food intake, body weight, and fasting blood glucose levels among the groups. Postoperatively, the SG-PTB and SG-TB groups showed significantly superior glucose control compared to the SG group following the gavage of glucose (p < 0.05). Postoperatively, the SG-PTB and SG-TB groups had higher postoperative GLP-1 levels than postoperative SG and SHAM groups. More severe esophageal hyperpapillomatosis (EHP) of the esophageal section was observed in the SG group. The mucosal height of the SG group was significantly higher than that of the SG-PTB, SG-TB, and SHAM groups (p < 0.05).

Conclusion

The transit bipartition procedure may protect the distal esophagus from histological changes associated with esophagitis. Clinical studies are needed to confirm the anti-reflux effects of transit bipartition.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Santoro S, Malzoni CE, Velhote MC, Milleo FQ, Santo MA, Klajner S, Damiani D, Maksoud JG. Digestive Adaptation with Intestinal Reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006 Oct;16(10):1371–9.

    Article  Google Scholar 

  2. Yormaz S, Yılmaz H, Ece I, Sahin M. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018 Jan;28(1):77–86.

    Article  Google Scholar 

  3. Cagiltay E, Celik A, Dixon JB, Pouwels S, Santoro S, Gupta A, Ugale S, Abdul-Ghani M. Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-cell peptides: results from the HIPER-1 study. Diabet Med. 2020 Apr;37(4):697–704.

    Article  CAS  Google Scholar 

  4. Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surg Obes Relat Dis. 2020;16(4):497–502.

    Article  Google Scholar 

  5. Topart P, Becouarn G, Finel JB. Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity. Obes Surg. 2020;30(9):3402–7.

    Article  Google Scholar 

  6. Ece I, Yilmaz H, Yormaz S, Çolak B, Calisir A, Sahin M. The short-term effects of transit bipartition with sleeve gastrectomy and distal-Roux-en-Y gastric bypass on glycemic control, weight loss, and nutritional status in morbidly obese and type 2 diabetes mellitus patients. Obes Surg. 2021 May;31(5):2062–71.

    Article  Google Scholar 

  7. Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782–95.

    Article  Google Scholar 

  8. Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS Randomized Clinical Trial. JAMA. 2018 Jan 16;319(3):255–65.

    Article  Google Scholar 

  9. Yeung KTD, Penney N, Ashrafian L, Darzi A, Ashrafian H. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: A systematic review and meta-analysis. Ann Surg. 2020 Feb;271(2):257–65.

    Article  Google Scholar 

  10. Genco A, Castagneto-Gissey L, Lorenzo M, Ernesti I, Soricelli E, Casella G. Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis. 2021 May;17(5):848–54.

    Article  Google Scholar 

  11. Felinska E, Billeter A, Nickel F, Contin P, Berlth F, Chand B, Grimminger P, Mikami D, Schoppmann SF, Müller-Stich B. Do we understand the pathophysiology of GERD after sleeve gastrectomy? Ann N Y Acad Sci. 2020 Dec;1482(1):26–35.

    Article  Google Scholar 

  12. Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.

    Article  Google Scholar 

  13. Del Genio G, Tolone S, Limongelli P, et al. Sleeve gastrectomy and development of “de novo” gastroesophageal reflux. Obes Surg. 2014 Jan;24(1):71–7.

    Article  Google Scholar 

  14. Altieri MS, Shroyer KR, Pryor A, Pagnotti GM, Ete Chan M, Talamini M, Telem DA. The association between sleeve gastrectomy and histopathologic changes consistent with esophagitis in a rodent model. Surg Obes Relat Dis. 2015;11(6):1289–94.

    Article  Google Scholar 

  15. Widjaja J, Dolo PR, Zhang Q, et al. Bypassed and preserved stomach resulted in superior glucose control in Sprague-Dawley rats with streptozotocin-induced diabetes. Sci Rep. 2019;9(1):9981.

    Article  Google Scholar 

  16. Liu P, Widjaja J, Dolo PR, Yao L, Hong J, Shao Y, Zhu X. Comparing the anti-diabetic effect of sleeve gastrectomy with transit bipartition against sleeve gastrectomy and Roux-en-Y gastric bypass using a diabetic rodent model. Obes Surg. 2021 May;31(5):2203–10.

    Article  Google Scholar 

  17. Fisher OM, Chan DL, Talbot ML, et al. Barrett’s oesophagus and bariatric/metabolic surgery-IFSO 2020 position statement. Obes Surg. 2021 Mar;31(3):915–34.

    Article  Google Scholar 

  18. Felsenreich DM, Kefurt R, Schermann M, Beckerhinn P, Kristo I, Krebs M, Prager G, Langer FB. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017 Dec;27(12):3092–101.

    Article  Google Scholar 

  19. Qumseya BJ, Qumsiyeh Y, Ponniah SA, Estores D, Yang D, Johnson-Mann CN, Friedman J, Ayzengart A, Draganov PV. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021 Feb;93(2):343-352.e2.

    Article  Google Scholar 

  20. Mala T. The gastric remnant in Roux-en-Y gastric bypass: challenges and possibilities. J Clin Gastroenterol. 2016 Aug;50(7):527–31.

    Article  Google Scholar 

  21. Tornese S, Aiolfi A, Bonitta G, Rausa E, Guerrazzi G, Bruni PG, Micheletto G, Bona D. Remnant gastric cancer after Roux-en-Y gastric bypass: narrative review of the literature. Obes Surg. 2019 Aug;29(8):2609–13.

    Article  Google Scholar 

  22. Andreollo NA, Santos EF, Araújo MR, Lopes LR. Rat’s age versus human’s age: what is the relationship? Arq Bras Cir Dig. 2012;25(1):49–51.

    Article  Google Scholar 

  23. Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013 Jun;4(6):624–30.

    PubMed  PubMed Central  Google Scholar 

  24. Grice HC. Safety evaluation of butylated hydroxyanisole from the perspective of effects on forestomach and oesophageal squamous epithelium. Food Chem Toxicol. 1988 Aug;26(8):717–23.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by the Science and Technology Program Project of Xuzhou (KC19157).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaocheng Zhu.

Ethics declarations

Statement of Informed Consent

Not applicable.

Statement of Animal Right

All applicable institutional and national guidelines of the People’s Republic of China for the care and use of animals were followed.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• A more severe esophageal hyperpapillomatosis (EHP) of the esophageal section was observed in the sleeve gastrectomy (SG) group, but not in the sleeve gastrectomy with transit bipartition (SG-TB) and sleeve gastrectomy with proximal transit bipartition (SG-PTB).

• Compared to SG, SG-TB may protect the distal esophagus from the histological changes associated with esophagitis.

• There is no significant difference esophageal hyperpapillomatosis (EHP) of the esophageal section between the SG-TB and SG-PTB models.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Widjaja, J., Dolo, P.R. et al. The Protective Effect of Transit Bipartition and Its Modification Against Sleeve Gastrectomy-Related Esophagitis in a Rodent Model. OBES SURG 32, 1149–1156 (2022). https://doi.org/10.1007/s11695-022-05907-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-022-05907-2

Keywords

Navigation